Skip to main content

I G 225 (Gemfibrozil 600 mg)

Pill with imprint I G 225 is White, Elliptical/Oval and has been identified as Gemfibrozil 600 mg. It is supplied by Cipla USA, Inc.

Gemfibrozil is used in the treatment of hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia; high cholesterol; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Gemfibrozil 600 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for I G 225

Gemfibrozil 600 mg I G 225
Gemfibrozil 600 mg I G 225
Gemfibrozil 600 mg I G 225 Front
Gemfibrozil 600 mg I G 225 Back
Gemfibrozil 600 mg I G 225

Gemfibrozil

Imprint
I G 225
Strength
600 mg
Color
White
Size
19.00 mm
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA, Inc.
Manufacturer
InvaGen Pharmaceuticals, Inc.
National Drug Code (NDC)
69097-0821
Inactive Ingredients
silicon dioxide, croscarmellose sodium, calcium stearate, microcrystalline cellulose, methylcellulose (15 mPa.s), hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), polyethylene glycol 400, polysorbate 80

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "I G 225"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.